{{Rsnum
|rsid=299175
|Gene=NLRP11
|Chromosome=19
|position=55802162
|Orientation=minus
|GMAF=0.4137
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=NLRP11
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 24.8 | 55.8 | 19.5
| HCB | 38.7 | 52.6 | 8.8
| JPT | 44.2 | 47.8 | 8.0
| YRI | 33.6 | 51.4 | 15.1
| ASW | 28.1 | 52.6 | 19.3
| CHB | 38.7 | 52.6 | 8.8
| CHD | 36.7 | 50.5 | 12.8
| GIH | 39.6 | 45.5 | 14.9
| LWK | 17.3 | 52.7 | 30.0
| MEX | 27.6 | 48.3 | 24.1
| MKK | 41.0 | 48.7 | 10.3
| TSI | 34.3 | 49.0 | 16.7
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19010793
|Trait=Multiple sclerosis (severity)
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000004
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs299175
|Name_s=
|Gene_s=NLRP11
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 794 cases, 883 controls; Replication Sample Size: NR); (Region: 19q13.42; Reported Gene(s): NLRP11; Risk Allele: rs299175-?); (p-value= 0.000004).This variant is associated with Multiple sclerosis (severity).
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740733
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs299175
|overall_frequency_n=41
|overall_frequency_d=128
|overall_frequency=0.320312
|n_genomes=29
|n_genomes_annotated=0
|n_haplomes=38
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}